about
Shortcomings in the current treatment of epilepsySulthiame add-on therapy for epilepsySulthiame monotherapy for epilepsySulthiame add-on therapy for epilepsySulthiame monotherapy for epilepsySulthiame add-on therapy for epilepsyEpilepsy in India I: Epidemiology and public healthCurrent prospects and challenges for epilepsy gene therapyEffects of anterior thalamic nucleus deep brain stimulation in chronic epileptic ratsThe roles of variants in human multidrug resistance (MDR1) gene and their haplotypes on antiepileptic drugs response: a meta-analysis of 57 studiesAstroglial networks and implications for therapeutic neuromodulation of epilepsy.The promise of new antiepileptic drugs.Evaluation of machine learning algorithms for treatment outcome prediction in patients with epilepsy based on structural connectome data.Psychosocial outcome of young adults with epilepsy in childhood.Incidence of sudden unexpected death in an adult outpatient cohort with epilepsy at a tertiary referral centreEpilepsy in a population of 6000 re-examined: secular trends in first attendance rates, prevalence, and prognosis.Epidemiology of the epilepsies.Recurrent seizures in patients with dementia: frequency, seizure types, and treatment outcomeIncidence of convulsive epilepsy in a rural area in KenyaReferral pattern for epilepsy surgery after evidence-based recommendations: a retrospective study.New anti-epileptic drugs.Lacosamide for the prevention of partial onset seizures in epileptic adults.The natural history of epilepsy: an epidemiological view.Levetiracetam: a novel antiepileptic drug.Antiepileptic drug utilization in Bangladesh: experience from Dhaka Medical College HospitalThe outcome of children with intractable seizures: a 3- to 6-year follow-up of 67 children who remained on the ketogenic diet less than one year.Neurologic consultation for seizures. When, why, and how to pursue.Update on the epidemiology and prognosis of pediatric epilepsy.Anti-kindling Effect of Bezafibrate, a Peroxisome Proliferator-activated Receptors Alpha Agonist, in Pentylenetetrazole Induced Kindling Seizure Model.Novel anticonvulsant medications in development.Sudden unexpected death in epilepsy: an important concern.Risk factors for recurrence of epilepsy and withdrawal of antiepileptic therapy: a practical approach.Incidence of epilepsy: a systematic review and meta-analysis.Treatment of epilepsy in China: Formal or informal.Discontinuing antiepileptic drugs in patients who are seizure free on monotherapy.Synthesis and anticonvulsant activity of some potent 5,6-bis aryl 1,2,4-triazinesThe role of common variation in drug transporter genes in refractory epilepsy.Epilepsy--success in clinical practice: translating trials to practice.Topiramate and its clinical applications in epilepsy.High resolution magnetic resonance imaging in adults with partial or secondary generalised epilepsy attending a tertiary referral unit.
P2860
Q22305925-5DE2E186-0AF9-4A74-B8D4-CA49469CA0DFQ24186338-0A2C1AAD-6FB3-4245-ACF2-1ACF7458E151Q24198006-4FAC57E5-EC1C-48E8-8BF1-1E74383A2B02Q24198277-F3EFD85C-BD53-4134-A894-66D696AFFD48Q24200968-FB2B5A2B-5CBA-4A6D-A11D-996BCDDEF75FQ24234912-587C439B-6C2F-47EC-8EC7-E072131146C7Q26783630-8874F649-59AF-4B8C-851F-69EFEC19BF1AQ27002627-C4DF0B85-6337-4E34-B9B8-490CCAC90D99Q27332096-DDBACA05-4235-47AC-84FB-B8886F9FDD27Q28545116-4A3C48E9-824C-4D1B-BC24-6FC4E1471CEBQ30524466-E5A78BB6-4FAA-4DD8-92AD-47B473933B3BQ30674774-068417C6-8D46-4D58-9337-546C00BE5D79Q30967973-278CAE91-9CD8-49C6-9CF4-6F99C3EC96FEQ33714986-AC9DE9EC-26F9-4E32-B83C-5A79B720B347Q33733974-F056C14B-7AB1-4291-BE74-2FCDDA852DB6Q33734098-D33D44D6-9DD9-4C35-BE78-FA709BAEA365Q33735546-7B16B179-FD76-41C6-83FD-DDFBFD66D6F5Q33873760-8DA771A9-0947-4E86-A0CC-01F63810EDB6Q33967152-01CDFBEC-1F52-4443-8B97-970FE20AE69DQ34098642-B12C3288-3FA9-445E-A9D0-5D0761983AD1Q34119473-C9697367-F4EB-4946-B268-791BBB8E11E8Q34122954-9AE2B37B-1D98-4B1C-A0C3-91D3E6ADCB6AQ34349568-273AF275-5A5A-4531-B8FB-3217B498E5B7Q34443362-13547723-5D68-4440-A13B-26727909A21DQ34477637-1CC53947-EC8F-464B-9C11-229F3444DEFCQ34497520-505E6A93-2C8E-4B88-B3D6-07538E1E1A05Q34505841-51D1694F-C76A-4A5E-BDA8-064ADE284577Q34579443-9A631DEF-3B94-4E80-B950-1C439FC27BFBQ34965339-40624079-B6A3-4841-95B7-E45A82F1D5C8Q34974862-3ABC35C1-0316-4A97-9CBB-A324AA87EA0DQ35054981-42603182-FB46-42F8-B5CC-0F7ED051B12EQ35160999-73B82583-FD93-49BD-93E6-43BB2B3B0F0CQ35210256-D6DD8EFA-06AC-444C-A987-3AC2104872AEQ35245431-EF3A1926-56DB-434A-A208-1D592A3032CAQ35465019-8F338FE3-5EF8-4D36-BC66-E2A35CD2CE93Q35868555-B5A0C2A0-21F8-4D8A-9685-EAA32BBF3DD9Q36192748-41D78F0C-0947-45B7-9E19-92B13D54B2E0Q36249988-6B36D25B-57EA-4CA3-AD0E-D9B78CFC4C67Q36429751-7D100258-842F-46F8-9AA3-6FC50F7A4C7CQ36882383-D7438A04-202A-4078-93FF-651654740E07
P2860
description
1993 nî lūn-bûn
@nan
1993年の論文
@ja
1993年学术文章
@wuu
1993年学术文章
@zh-cn
1993年学术文章
@zh-hans
1993年学术文章
@zh-my
1993年学术文章
@zh-sg
1993年學術文章
@yue
1993年學術文章
@zh
1993年學術文章
@zh-hant
name
Some aspects of prognosis in the epilepsies: a review.
@en
type
label
Some aspects of prognosis in the epilepsies: a review.
@en
prefLabel
Some aspects of prognosis in the epilepsies: a review.
@en
P2860
P1433
P1476
Some aspects of prognosis in the epilepsies: a review.
@en
P2860
P304
P356
10.1111/J.1528-1157.1993.TB02126.X
P50
P577
1993-11-01T00:00:00Z